Project Grant R15HL181624
Award Date 7/10/26
Completion Date 6/30/29
Dollars Obligated $445K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Southfield, MI 48075, USA
Similar Awards
- Federal Project Grant Award Summary The University of Michigan received a $1,494,562 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 20, 2025, with completion targeted for June 30, 2030. The award supports the development of an innovative in situ micro-rheology technique utilizing ultrasound-responsive nanodroplets to non-invasively characterize aging thrombi in real-time. The core...
- Federal Grant Award Summary Michigan Technological University received a $410,956 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2028. The award supports research titled "Stratifying Thrombosis Risk in Kawasaki Disease Using Hemodynamic Analysis Beyond the Z-Score," which addresses the clinical challenge of identifying thrombotic risk in patients...
- Federal Project Grant Award Summary Massachusetts Institute of Technology received a $397,034 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion scheduled for July 31, 2027. The grant supports development of a transcatheter manufacturing toolkit for creating patient-specific, minimally-invasive left atrial appendage occlusion (LAAO) devices to prevent stroke in...
- Federal Grant Award Summary Michigan Technological University received a $589,998 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2028. The award supports research investigating cardiac sensory and sympathetic nerve dysregulation in hypertrophic cardiomyopathy (HCM), a genetic heart disease affecting approximately 1 in 500 individuals and representing the...
- Federal Project Grant Award Summary Wayne State University received a $756,148 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 1, 2026, with completion targeted for March 31, 2030. The award supports development of next-generation enabling technologies for ultrafast functional pulmonary magnetic resonance imaging (MRI) using hyperpolarized xenon-129 gas. The project addresses a critical...
- Federal Grant Award Summary Lawrence Technological University received a $422,247 Project Grant from the National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems (CFDA 47.041) awarded on September 15, 2025, with completion targeted for December 31, 2026. This collaborative research initiative, conducted in partnership with the University of Texas at El Paso and Baylor College of Medicine, investigates the interaction between nanometer-scale...
- Federal Project Grant Award Summary Oakland University received a $249,000 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on August 11, 2025, with a completion date of July 31, 2028. The research focuses on pre-mRNA processing and function of alternatively spliced isoforms of Tissue Factor Pathway Inhibitor (TFPI), a critical anticoagulant protein that maintains hemostatic balance by modulating...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Massachusetts a $425,971 Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) effective July 6, 2026, through June 30, 2028, to develop a biomaterials-integrated microphysiological bone marrow chip model. The project aims to create a physiologically relevant preclinical system that recapitulates the structural and functional interdependence of bone and bone marrow...
- Federal Project Grant Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $191,629 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective May 15, 2026, with completion targeted for April 30, 2031. The research addresses venous thromboembolism (VTE) risk in pregnant and postpartum patients with sickle cell disease (SCD), a medically vulnerable...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $429,000 Project Grant to the Regents of the University of Michigan on August 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop a rapid, non-contrast, low-field magnetic resonance imaging (MRI) pipeline for detecting pulmonary embolism (PE). The project, which extends through July 31, 2027, focuses on creating an efficient 3D, contrast-free MRI protocol utilizing...